Three strategies for managing loss of exclusivity successfully
pharmaphorum
FEBRUARY 18, 2021
6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Between December 1, 2018 and January 31, 2019, 65% of erectile dysfunction prescriptions filled were for Viagra or its generic version 12.
52 
Let's personalize your content